Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase-II Study Comparing Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Following Autologous Transplantation to Autologous Transplantation Alone in Multiple Myeloma

NCT05082675 is registered in ClinicalTrials.gov with European Society for Blood and Marrow Transplantation as lead sponsor.

NCT NCT05082675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05082675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase-II Study Comparing Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Following Autologous Transplantation to Autologous Transplantation Alone in Multiple Myeloma
Lead sponsor
European Society for Blood and Marrow Transplantation
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
January 31, 2012
Enrollment
357 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma